Top award for Aids researcher

File photo: Nacho Doce

File photo: Nacho Doce

Published Oct 23, 2015

Share

Durban - A leading Aids researcher based in Durban has bagged a sought-after award for his work in the field.

Professor Salim Abdool Karim is the latest recipient of the South African Medical Research Council’s (SAMRC) Platinum Medal, a lifetime achievement award, given to an outstanding scientist who has contributed substantially to improving health through research and helped build the foundations of health research in the country for future generations.

An accomplished scientist who has dedicated more than 30 years to social justice, human rights activism and scientific research, Karim has made several important breakthroughs ranging from treatment for HIV-TB co-infected people to new approaches to prevent HIV infections. Commenting on his current research, which focuses mainly on innovative technologies to prevent HIV, he said: “We won’t stop HIV in young women tomorrow…. but it has to be part of our long-term vision”.

He told the Daily News he was humbled by the award.

“I suppose this means I’m a golden oldie now,” he said, laughing. He said: “Impressive progress in scientific discovery, resource mobilisation, political commitment and implementation has been achieved, but young women in Africa still have high HIV rates. Each day there are about 1 000 new infections in South Africa.”

Karim – Pro vice-chancellor for research at the University of KwaZulu-Natal and professor in Clinical Epidemiology at the Mailman School of Public Health at Columbia University – also established the award-winning research institute, Caprisa.

He also chairs the Scientific Expert Panel of the Joint UN Programme on Aids, UNAids and is a member of the World Health Organisation’s HIV-TB Task Force and the WHO Expert Panel on Sexually Transmitted Infections and HIV.

The award will be presented at the SAMRC Scientific Merit Awards Evening in Cape Town on Thursday next week.

Daily News

* E-mail your opinion to [email protected] and we will consider it for publication or use our Facebook and Twitter pages to comment on our stories. See links below.

Related Topics: